TY - JOUR
T1 - Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent™
T2 - The Antares study
AU - Bartorelli, Antonio L.
AU - Trabattoni, Daniela
AU - Montorsi, Piero
AU - Fabbiocchi, Franco
AU - Galli, Stefano
AU - Ravagnani, Paolo
AU - Grancini, Luca
AU - Cozzi, Sergio
AU - Loaldi, Alessandro
PY - 2002
Y1 - 2002
N2 - The effect of stent coatings in preventing early thrombotic occlusion remains to be proved. The purpose of this study was to evaluate the safety and efficacy of the Carbostent™, a new coronary stent with a nonthrombogenic coating (Carbofilm™), in 110 consecutive patients (73.6% men, mean age 61 ± 9 years) who met prespecified clinical and angiographic inclusion criteria and were treated with aspirin monotherapy after stenting. Stable angina (75.5%), unstable angina (18.2%), and silent ischemia (6.3%) were clinical indications for coronary revascularization. Patients received 10,000 U of heparin and no IIb/IIIa inhibitors or postprocedural heparin. Complex lesion characteristics (B2, C) were present in 39 out of 129 (30.2%) lesions. Mean lesion length was 15.6 ± 7.4 mm, and 32% of the lesions were >15 mm (range 16-52 mm). Small coronary vessels (
AB - The effect of stent coatings in preventing early thrombotic occlusion remains to be proved. The purpose of this study was to evaluate the safety and efficacy of the Carbostent™, a new coronary stent with a nonthrombogenic coating (Carbofilm™), in 110 consecutive patients (73.6% men, mean age 61 ± 9 years) who met prespecified clinical and angiographic inclusion criteria and were treated with aspirin monotherapy after stenting. Stable angina (75.5%), unstable angina (18.2%), and silent ischemia (6.3%) were clinical indications for coronary revascularization. Patients received 10,000 U of heparin and no IIb/IIIa inhibitors or postprocedural heparin. Complex lesion characteristics (B2, C) were present in 39 out of 129 (30.2%) lesions. Mean lesion length was 15.6 ± 7.4 mm, and 32% of the lesions were >15 mm (range 16-52 mm). Small coronary vessels (
KW - Antiplatelet therapy
KW - Coated stents
KW - Stent thrombosis
KW - Thromboresistance
UR - http://www.scopus.com/inward/record.url?scp=0036158478&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036158478&partnerID=8YFLogxK
U2 - 10.1002/ccd.10037
DO - 10.1002/ccd.10037
M3 - Article
C2 - 11835638
AN - SCOPUS:0036158478
VL - 55
SP - 150
EP - 156
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
SN - 1522-1946
IS - 2
ER -